Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.935 USD | -4.40% |
|
+9.51% | +101.40% |
07-16 | ChromaDex Corp. Announces Pharmaceutical-Grade Intravenous and Injectable Niagen®? Will Debut At Leading Wellness Clinics in August | CI |
07-01 | ChromaDex Joins Russell 2000 Index | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+101.40% | 232M | |
+23.95% | 47.96B | |
+0.24% | 42.45B | |
+43.96% | 41.47B | |
+25.83% | 31.6B | |
+20.59% | 28.63B | |
-4.47% | 28.03B | |
+51.32% | 14.56B | |
+44.56% | 14.14B | |
+1.90% | 12.58B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- ChromaDex Corp. Appoints Mark Friedman as General Counsel and Corporate Secretary